Search Contract Opportunities

FY25: CEPHEID Molecular Platforms Reagents B+4   2

ID: 36C24825Q0311 • Type: Award Notice • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Overview

Awardee
Award ID
36C24825D0023
Reported Award
$4,986,000
Award Date
June 6, 2025
Posted
June 6, 2025, 7:29 a.m. EDT
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1250 Employees
Pricing
Likely Fixed Price
FY25: CEPHEID Molecular Platforms Reagents B+4 (36C24825Q0311) was awarded to Cepheid on 6/6/25 by VISN 8: Sunshine Healthcare Network.
Primary Contact
Title
Contracting Officer
Name
Benjamin Amato   Profile
Phone
(407) 646-4005

Documents

Posted documents for Award Notice 36C24825Q0311

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Award Notice 36C24825Q0311

Award Notifications

Agency published notification of awards for Award Notice 36C24825Q0311

IDV Awards

Indefinite delivery vehicles awarded through Award Notice 36C24825Q0311

Similar Active Opportunities

Open contract opportunities similar to Award Notice 36C24825Q0311

Experts for FY25: CEPHEID Molecular Platforms Reagents B+4

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > 248-NETWORK CONTRACT OFFICE 8 (36C248)
FPDS Organization Code
3600-00248
Source Organization Code
100167097
Last Updated
June 21, 2025
Last Updated By
Benjamin.Amato@va.gov
Archive Date
June 21, 2025